NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
(855) 940-4867
Medically reviewed on by
Regional Medical Director Greater St. Louis
After decades of limited choices in the treatment of depression, ketamine and other medications related to it have taken off as promising new options for those who still suffer. It just might be the treatment for depression that you’ve been waiting for.
Surprisingly, ketamine was originally used as an anesthetic for surgery. Approved in 1970, it was especially useful in some special situations, including emergency surgery in the battlefield. It is sometimes used for anesthesia even today, and it is also commonly used for anesthesia in veterinary medicine. It’s been called a “horse tranquilizer” because, well, it’s been used to tranquilize horses.
Ketamine has also occasionally been a drug of abuse. The FDA categorizes ketamine as a Schedule III drug, which means it has a low or moderate potential for abuse. Ketamine abuse is rare. But still, ketamine as a drug of abuse has acquired some colorful street names such as “special K” and “blind squid.”
The history of ketamine took a surprising turn around 2009 when there were the first reports of a sudden improvement in depression among some people treated with ketamine. People sometimes improved almost immediately with ketamine, and that was in sharp contrast to the several weeks needed for improvement with antidepressants. This rapid improvement with ketamine contradicted what we thought we knew about medicine for depression, and it sounded too good to be true. But, further research into ketamine and ketamine-like drugs proved that the benefit was real. Finally, one of these drugs, esketamine, gained FDA approval in 2019. Esketamine (pronounced like “s-ketamine”) is just one of many treatments recently approved or on the horizon. Psychedelics such as psilocybin, for example, are a possible treatment in the future. New treatments often work when standard treatments such as antidepressants and therapy have failed – so new options give hope to countless people who still suffer from depression.
Esketamine is given as a nasal spray. And, because it’s already FDA-approved, it is usually covered by insurance. We offer that medication at Greenbrook.
Greenbrook TMS is a certified esketamine nasal spray provider. In a typical esketamine nasal spray treatment schedule, you’ll receive two treatments per week for four weeks, and then one treatment per week for the next four weeks. After that, treatment is typically once every one or two weeks.
You’ll receive your treatment in a relaxing area, in a comfy chair in your own private room or cubicle. Throughout your two-hour session, your care team will monitor you, and will be available if you need anything. In addition, the medical provider will be nearby, and will make rounds during your treatment to assess how you are doing.
Are you ready to take the next step in your journey to relieving symptoms of depression? To learn more about your options,
schedule your free consultation with Greenbrook TMS or give us a call at 855-940-4867 today. We offer both esketamine, and
TMS (transcranial magnetic stimulation).
Thanks for subscribing to our list!
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.